A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

PHILADELPHIA ­— At the recent American Heart Association meeting, a cavernous room full of doctors erupted into applause. Cleveland Clinic cardiologist A. Michael Lincoff had just presented the ...

The drug’s effects on cardiovascular and inflammation markers outshined its failure to spur weight loss, analysts wrote.

The Asia-Pacific region leads the cardiovascular drug market, driven by reforms and expanding healthcare infrastructure, which also boost opportunities for local companies and increase competition for ...

AUSTIN, Texas and TOKYO, Oct. 13, 2025 /PRNewswire/ -- The cardiovascular drugs market was valued at US$ 174.6 billion in 2024 and is projected to reach US$ 247.8 billion by 2033, achieving a CAGR of ...

Rheumatoid arthritis (RA) disease activity and inflammatory markers are associated with major adverse cardiovascular events (MACEs) in biologic disease-modifying antirheumatic drug (bDMARD) nonusers ...